In a study on Caucasian NAFLD patients, the presence of the IL-6 rs1800795 C allele accompanied an escalated risk for severe steatosis, whereas it was associated with less IL-6 expression in the liver and lower progressive inflammation and fibrosis [149]. The gene discussed is IL6; the disease is metabolic dysfunction-associated steatotic liver disease.